Disease Lead, Thoracic Medical Oncology

Employer
Jefferson Health
Location
Philadelphia, Pennsylvania
Salary
Commensurate with experience
Posted
Jun 22, 2021
Closes
Jul 22, 2021
Education
DO, MD
Hours
Full Time

Disease Lead, Thoracic Medical Oncology

The Sidney Kimmel Cancer Center (SKCC) at Jefferson Health, in partnership with the Department of Medical Oncology, is seeking a recognized thought leader in clinical and scientific aspects of lung cancer and related malignancies to fill the position of Disease Lead, Thoracic Medical Oncology, an enterprise-wide role.

As part of a dynamic period of expansion and integration, leaders at Jefferson Health and the NCI-designated Sidney Kimmel Medical Center are committed to growing the faculty and resources of the Department of Medical Oncology. While successful research and clinical activities for lung cancer have been ongoing in the Departments of Surgery, Medical Oncology, Radiation Oncology, and at the SKCC, there is a broad recognition that overall program development and clinical trials activity could be greatly enhanced by additional medical oncology leadership that will stimulate the clinical trials and translational portfolios of the Section.

The successful candidate will hold a primary appointment in Medical Oncology, while sharing the responsibility for further developing and coordinating Jefferson’s multidisciplinary clinical and investigational program in Thoracic Malignancies, ensuring a collaborative approach to studying and treating these malignancies across the Departments and Jefferson Enterprise which includes the Advanced Care Hubs. The Disease Lead will be responsible for overseeing the clinical and translational research portfolio and clinical operations of the section of Thoracic Oncology and facilitating these services throughout the enterprise. They will also engage to promote and enhance the program to internal and external audiences. This will include strengthening collaborative group clinical trials participation, designing and activating investigator-initiated trials, cementing communications and working relationships between the principal disciplines involved in the diagnosis and management of Thoracic Malignancies at Jefferson, and representing the perspectives and needs of Thoracic Malignancies within the Cancer Service Line at Jefferson.

This is an exceptional opportunity for a physician to join this department during a transformational period of growth of the Cancer Center and realize the vision of a research-driven, world class program. 

Required Qualifications

  • MD/DO from an accredited School of Medicine.
  • A Board-Certified medical oncologist with a national reputation for leadership in thoracic oncology who is fluent with current clinical and scientific literature in this field.
  • Five years of experience within an advanced academic environment combined with proven communication, organizational, analytical, and relationship skills. 
  • A strong record of successful program development, clinical research, as well as translational research including investigator/institutionally initiated as well as industry sponsored drug development and Phase I trial activity.
  • Academic qualifications for appointment at the level of Associate or Full Professor at Sidney Kimmel Medical College and a level of scientific credibility that will bring respect from clinician-investigators and scientists at SKCC.
  • Aptitude and demonstrated accomplishment in collaborating in multidisciplinary programs, achieving consensus on clinical and research strategies across traditional boundaries, and in successfully navigating a collegial yet highly matrixed environment.
  • Demonstrated leadership in thoracic oncology research, to include a track record of obtaining NIH and other federal research funding as the principal investigator, together with a record of publications in prominent peer-reviewed journals.
  • A demonstrated track record in faculty recruitment. Experience in leading multidisciplinary teams and mentoring of junior faculty, students and staff.
  • Ability and enthusiasm to continue to advance SKCC’s tradition of successful bench to bedside research.
  • A collaborative approach which emphasizes partnership amongst and between clinical, basic, and population scientists in order to define and implement a comprehensive research agenda in thoracic malignancies.  

Interested parties may contact Alison Lebonitte, Vice President, Senior Associate at: JeffersonThoracic@divsearch.com